Composition

Each tablet of Nicetil contains 500 mg of L-Acetylcarnitine as the active ingredient. Other non-active components include microcrystalline cellulose, magnesium stearate, and silicon dioxide.

Description

Nicetil is a medication based on L-Acetylcarnitine, a biologically active form of L-carnitine that plays a vital role in cellular energy metabolism. It supports the transport of fatty acids into the mitochondria, where they are converted into energy. This mechanism makes Nicetil useful in various conditions associated with energy deficiency and metabolic disorders. Each box contains 30 tablets, each with 500 mg of the active substance.

Pharmacology

L-Acetylcarnitine contributes to efficient energy production, especially in tissues with high metabolic demand such as muscles and the nervous system. It also possesses antioxidant properties, helping to neutralize free radicals and reduce oxidative stress. Some research suggests its potential neuroprotective effects, which may benefit patients with cognitive decline.

Indications

Nicetil is indicated in the treatment of:

• L-carnitine deficiency states
• Peripheral neuropathies (including diabetic neuropathy)
• Age-related cognitive decline and Alzheimer’s disease (as adjunct therapy)

Contraindications

Do not use Nicetil if you are allergic to L-Acetylcarnitine or any other components of the formulation. It is also contraindicated in individuals with severe renal dysfunction.

Dosage and Administration

The standard recommended dose is 500 mg (1 tablet) twice daily. Tablets should be swallowed whole with water, with or without food. Dosage may be modified by a healthcare provider based on individual needs and clinical response.

Side Effects

Possible side effects include nausea, vomiting, abdominal discomfort, and diarrhea. Some users may experience restlessness, insomnia, or skin rash. If side effects persist or become bothersome, consult a medical professional.

Precautions

Before starting Nicetil, inform your doctor of any ongoing treatments, supplements, or chronic health conditions. Caution is advised during pregnancy, lactation, and in patients with seizure disorders.

Storage

Store at room temperature, away from moisture, heat, and direct light. Keep out of reach of children.

References

For further information on the clinical use and pharmacological effects of L-Acetylcarnitine, see:

[PubMed: Neuroprotective actions of Acetyl-L-carnitine]
[PubMed: Acetyl-L-carnitine in diabetic peripheral neuropathy]

The post Nicetil (L-Acetylcarnitine, 30 tabs × 500 mg) appeared first on MeDank Online Shop.

Composition

• Main active ingredient: Astragalus membranaceus extract (standardized polysaccharides).
• Inactive ingredients: Purified water, sodium chloride (solvent/stabilizer).

Pharmacological Action

Astragalus membranaceus is a traditional Chinese medicinal herb known for its broad spectrum of pharmacological actions, including immunostimulant, adaptogenic, anti-inflammatory, antioxidant, antiviral, and cardioprotective properties. It enhances T‑cell proliferation, increases macrophage and NK cell cytotoxic activity, modulates pro- and anti-inflammatory cytokines (e.g., IL‑2, IL‑6, TNF‑α, IFN‑γ), and regulates oxidative stress through upregulation of endogenous antioxidant enzymes like SOD and glutathione peroxidase. The key bioactive components responsible for these effects are Astragalus polysaccharides (APS), flavonoids, and saponins.

Indications

Astragalus injection is used as an adjunctive or supportive agent in the following conditions:

• Chronic fatigue syndrome and general physical exhaustion
• Cardiovascular disease, including viral myocarditis and heart failure
• Cancer immunotherapy to improve immune status and reduce chemotherapy-induced toxicity
• HIV/AIDS: to enhance immune function and reduce opportunistic infections
• Recurrent respiratory tract infections (upper and lower)
• Renal disorders including nephrotic syndrome (via podocyte protection)
• Adjunct to seasonal flu prevention and recovery

Contraindications

• Autoimmune diseases (e.g., lupus erythematosus, multiple sclerosis, rheumatoid arthritis), as immune stimulation could exacerbate symptoms.
• Pregnancy and breastfeeding – insufficient data on safety in these populations.
• Known hypersensitivity to Astragalus or any of the excipients.

Administration and Dosage

The dosage of Astragalus injection depends on the therapeutic goal and patient condition. Typical regimens include:

• Intramuscular injection: 2–4 ml once daily or every other day.
• Intravenous drip (diluted): 10–20 ml diluted in 250 ml normal saline, once daily for 10–20 days (commonly used in hospital settings for immunosuppression or myocarditis).

Treatment cycles may last 10–21 days, followed by rest periods.

Side Effects

Astragalus injection is generally well tolerated. However, possible side effects include:

• Mild gastrointestinal discomfort (e.g., nausea, bloating)
• Localized skin rash or allergic reaction at injection site
• Headache or dizziness (rare)
• Altered blood coagulation profiles in high doses or long-term use

Severe adverse events are rare and typically resolve upon discontinuation.

Drug Interactions

• May reduce the effectiveness of immunosuppressant medications (e.g., corticosteroids, cyclosporine).
• May enhance the effects of anticoagulants – monitor INR and bleeding risk.
• Can influence the outcomes of lab tests involving cytokine assays or immune parameters.

Overdose and Treatment

Signs of overdose include gastrointestinal distress, fatigue, hypotension, or immune overstimulation. Treatment includes cessation of therapy, monitoring of vitals, and supportive care.

Storage

• Store between 15–25°C (room temperature), away from sunlight and moisture.
• Do not freeze.
• Use immediately after opening the vial.
• Keep out of reach of children and pets.

Mechanism of Action

Astragalus polysaccharides (APS) are the main active constituents and exert immunomodulatory effects through:

• Stimulation of macrophage phagocytic activity
• Enhancement of lymphocyte proliferation and NK cell cytotoxicity
• Regulation of pro- and anti-inflammatory cytokines (e.g., suppression of TNF-α, IL-6 via NF-κB pathway inhibition)
• Antioxidant action through scavenging ROS and upregulating antioxidant enzymes
• Cardioprotective and renoprotective properties via regulation of oxidative stress and inflammation

Clinical Studies and Evidence

A 2025 meta-analysis of 14 randomized controlled trials demonstrated that Astragalus injection significantly improved clinical outcomes in patients with viral myocarditis, reducing cardiac enzyme markers (CK-MB, LDH) and improving ECG parameters. Qian et al., 2025

A systematic review published in the Journal of Traditional Chinese Medicine highlighted Astragalus as an effective adjunctive agent in cancer patients, improving immune profiles and reducing chemotherapy-induced leukopenia. Piao et al., 2014

Use in Special Populations and Sports

In sports medicine, Astragalus is gaining popularity due to its adaptogenic properties:

• Supports post-exercise recovery by reducing inflammation and oxidative stress
• May enhance endurance through mitochondrial support and fatigue resistance
• Useful in overtraining syndrome by stabilizing immune response and reducing cortisol impact

Note: While not on the WADA prohibited list, athletes should consult a sports physician prior to use, as some immunomodulators can alter biological passport data or raise doping concerns.

In elderly or immunocompromised populations, Astragalus can serve as a preventive immune booster, but dosage should be tailored individually.

Additional Applications

• Renal protection: Astragalus has been shown to protect renal tubular cells, reduce proteinuria, and improve creatinine clearance in early-stage nephropathy.
• Liver support: Some studies suggest hepatoprotective effects via antioxidant and anti-inflammatory mechanisms.
• Diabetes adjunct: May improve glucose tolerance and insulin sensitivity through AMPK activation and reduced oxidative stress.

Formulations and Availability

Astragalus injection is typically available in 2 ml, 5 ml, or 10 ml ampoules at 1–2 g crude drug equivalent per 10 ml. It is a prescription-grade preparation in China and parts of Asia and may be available via international pharmacies for integrative medical practices.

Summary

Astragalus (Injection) Solution is a scientifically supported herbal immunomodulator and adaptogen with wide-ranging benefits. From immune enhancement to organ protection and stress resilience, its bioactive constituents target multiple physiological systems. Clinical trials support its use in viral myocarditis, immune suppression, and fatigue-related conditions. Though generally safe, usage should be guided by trained medical professionals, especially in athletes or individuals with autoimmune conditions.

References

• Qian et al., 2025 – Meta-analysis on Astragalus in viral myocarditis
• Piao et al., 2014 – Review of Astragalus in integrative oncology

The post Astragalus (injection) – 10 ampoules appeared first on MeDank Online Shop.

Glialia 700 is an ultramicronized oral suspension containing palmitoylethanolamide (PEA) 700 mg plus luteolin 70 mg in 10 ml per dose. Packaged as a 200 ml bottle with dosing syringe, it is designed for sublingual or oral administration. The formulation is optimized for neuroinflammatory support.

Composition

• Palmitoylethanolamide (ultramicronized form) – 700 mg per 10 ml
• Luteolin (ultramicronized) – 70 mg per 10 ml
• Excipients: water, corn dextrin, microcrystalline cellulose, sodium carboxymethylcellulose, polysorbate 80, potassium sorbate, citric acid

Pharmacological Action

This co‑ultramicronized formulation (PEALUT®) enhances absorption and bioavailability. PEA is an endogenous lipid mediator that modulates microglia, mast cells, and astrocytes, restoring neuro-glial homeostasis by reducing neuroinflammation, oxidative stress, and peripheral sensitization. Luteolin adds strong antioxidant and anti-inflammatory support, stabilizing mast cells and inhibiting NF‑κB and MAPK pathways.

Indications

Glialia 700 is indicated as a supportive treatment in:

• Neurological-inflammatory disorders such as post-stroke, mild cognitive decline, Parkinson’s, early neurodegeneration
• Post-traumatic brain injury or transient ischemic attacks
• Neuroinflammation-associated mood disorders or post-viral syndromes
• Chronic neuropathic pain, fibromyalgia, or persistent brain fog (e.g., post-COVID‑19)

Dosage and Administration

Typical dosing is 10 ml (one syringe) administered sublingually or orally 1–2 times daily for 20–30 days, potentially extendable to several cycles based on clinical response. Shake bottle before use. Suitable for use via nasogastric or PEG in cases of dysphagia.

Side Effects

• Occasional mild gastrointestinal discomfort (e.g., bloating)
• Rare headache or fatigue
• Possible mild skin reactions in sensitive individuals

Contraindications

• Pregnancy and breastfeeding—insufficient safety data
• Known hypersensitivity to PEA, luteolin, or formulation ingredients

Precautions

• Use under medical supervision—especially in patients with severe hepatic or renal impairment
• Monitor for potential interactions with immune-modulating therapies

Interactions

May interact with antiplatelet or anticoagulant medications. Patients taking warfarin or similar agents should monitor coagulation status. May influence results of cytokine or inflammatory biomarker assays.

Overdose and Treatment

No specific overdose cases reported. Excessive intake may lead to nausea or gastrointestinal discomfort. Cease administration and provide supportive care as needed.

Storage

• Store at room temperature (15–25 °C), protected from light and humidity
• Retain bottle tightly closed; use within expiration date
• Keep out of reach of children

Mechanism of Action

PEA binds PPAR‑α and exerts anti-nociceptive and anti-inflammatory effects, reducing mast cell degranulation and microglial activation. Luteolin enhances neuronal resilience by inhibiting inflammatory transcription factors and promoting antioxidant defenses. Together, PEA and luteolin restore neuroglial balance and support neuroprotection and synaptic stability.

Clinical Studies and Evidence

A randomized controlled trial in patients with long‑COVID-related cognitive symptoms showed that oral administration of Glialia® (ultramicronized PEA‑Luteolin, 700 mg + 70 mg daily) significantly improved measures of cortical excitability (LICI) and cognitive function compared to placebo. Versace et al., PMC 2022

A systematic review and meta-analysis published in Biomolecules (2023) confirmed that CoUltraPEALut improves recovery of olfactory function in post-COVID olfactory dysfunction (PCOD), with better TDI score outcomes when combined with olfactory training versus training alone. Capra et al., 2023

Use in Special Populations and Sports

Athletes and individuals subject to high cognitive or physical stress may benefit from Glialia’s anti-inflammatory and adaptogenic effects, including faster recovery, reduced fatigue, and improved mental clarity. Although not on WADA prohibited list, use in competitive settings should be managed by sports medicine professionals due to potential immunomodulatory and biomarker interactions.

Additional Notes

Co-ultramicronized PEA and luteolin (PEALUT®) allow for enhanced bioavailability and clinical efficacy at lower doses compared to non-ultramicronized forms. Use in elderly or frail patients may aid resilience and support quality of life, particularly in cognitive decline and sensory dysfunction.

Summary

Glialia 700 is an evidence-based neuronal support formulation combining palmitoylethanolamide and luteolin in an ultramicronized delivery form. It addresses neuroinflammation, oxidative stress, and neuronal dysfunction common to various CNS-related conditions. Supported by clinical trials in post-COVID cognitive and olfactory recovery, it offers a well-tolerated adjunct in neurological support under medical supervision.

References

• Versace et al. (2022) – PEA‑Luteolin neurophysiological study
• Capra et al. (2023) – Meta‑analysis in post‑COVID olfactory dysfunction

The post Glialia 700 (Syrup, 200 ml) appeared first on MeDank Online Shop.

Composition

• Each ampoule contains: Inosine 400 mg in 10 ml solution.
• Solvent: sterile water for injection; isotonic agent: sodium chloride.
• No preservative or additives—clear, colorless sterile solution.

Description

Inosine Injection is a sterile nucleoside preparation in glass ampoules (5 × 10 ml). Inosine is a purine nucleoside integral to nucleotide metabolism and energy production. Following parenteral administration, Inosine is rapidly deaminated to hypoxanthine and xanthine, ultimately increasing serum urate levels—a biochemical pathway with implications for cellular metabolism, antioxidant defense, and purine salvage pathways.

Pharmacological Action

Inosine exerts multiple systemic effects: it serves as an energy substrate via ribose metabolism, supports ATP production, promotes coronary vasodilation, improves myocardial bioenergetics, and demonstrates neuroprotective and immunomodulatory effects. Inosine has been shown to stimulate axonal growth in experimental models, reduce inflammatory cytokine expression (TNF‑α, IL‑1β, IL‑12), and support effector T‑cell bioenergetics under glucose deprivation. It also acts as an intermediary in purine metabolism, raising serum urate—an endogenous antioxidant—though elevated urate may carry risks in certain contexts.

Indications

Inosine Injection is indicated for:

• States of metabolic exhaustion or high energy demand (e.g. post-surgery, chronic fatigue, recovery phase of illness)
• Adjunctive support in cardiac conditions with impaired perfusion or energy metabolism
• Patients undergoing high-intensity physical activity who require improved oxygen utilization
• Selected neurological conditions or immune-modulating support, under experimental or off-label use

Contraindications

• Known hypersensitivity to inosine or any component.
• Gout, hyperuricemia, or crystal-induced arthropathies—serum urate elevation contraindicated.
• Pregnancy and breastfeeding—safety not established.
• Not recommended in pediatric patients under supervision—insufficient evidence.

Dosage and Administration

• Administer intravenously over 10–15 minutes per ampoule (400 mg).
• Typical adult dose: 1 ampoule daily; do not exceed 2 ampoules (800 mg) per day.
• Adjust injection speed and dosage per patient tolerance and renal function.

Side Effects

• Occasional mild allergic reactions—rash, itching, urticaria.
• Nausea, vomiting, lightheadedness, tachycardia.
• Elevated uric acid levels—risk of gout, kidney stones, nephropathy.
• Rare cardiovascular or renal adverse events, typically reversible upon cessation.

Precautions

Monitor serum uric acid periodically—especially in patients with prior hyperuricemia or cardiovascular risk. Advise limiting purine-rich foods and alcohol during treatment. Monitor renal and hepatic function if long-term usage is considered.

Interactions

• Concomitant use with xanthine oxidase inhibitors (e.g., allopurinol) may alter uric acid metabolism.
• May affect assays for cytokines or inflammatory biomarkers.
• Monitor synergy or interference with antiviral or immunomodulatory agents.

Overdose and Treatment

Overdose symptoms may include nausea, hypotension, dysrhythmias, or altered consciousness. Management is supportive: cease inosine, hydrate, correct electrolytes, and monitor vitals. Urate-lowering therapy may be considered if hyperuricemia is severe.

Storage

• Store at room temperature (15–25 °C), protected from direct sunlight.
• Do not freeze.
• Keep ampoules in original sealed packaging; use promptly after opening.
• Keep out of reach of children.

Mechanism of Action

Inosine is converted to hypoxanthine and ribose-1-phosphate, supporting ATP generation through glycolysis and the pentose phosphate pathway. It promotes vasodilation and cardiac energy metabolism, suppresses pro-inflammatory cytokines, and supports nerve regeneration via NGF-related pathways observed in preclinical models.

Clinical Studies and Evidence

A randomized clinical trial (SURE‑PD3) demonstrated that orally elevated serum urate via inosine is generally safe and tolerated over up to 24 months, though increased rates of nephrolithiasis were observed (7 per 100 patient‑years vs 1.4 in placebo). Bluett et al., 2021

A safety trial (Iwaki et al., 2017) involving early Parkinson’s patients confirmed one-year oral inosine (≈1070 mg/day) safely raised uric acid from ~3.5 mg/dL to ~6.7 mg/dL without severe adverse events; transient crystalluria noted. Iwaki et al., 2017

Use in Special Populations and Sports

Athletes may use inosine IV for recovery after intense exertion; by supporting ATP generation and metabolism, it may alleviate fatigue. However, the increase in serum urate poses a risk for gout or renal stones. Not prohibited by WADA, but professional supervision and uric acid monitoring are recommended.

Elderly or cardiac patients should receive careful dosing and lab monitoring due to altered renal clearance and urate handling.

Additional Notes

Emerging research highlights inosine’s role in immune cell metabolism: T lymphocytes can metabolize inosine as an alternative carbon source under glucose deprivation, supporting effector function and enhancing anti-tumor immunity in vitro. Wang et al., 2020 Additionally, murine studies show that inosine administration increases energy expenditure and thermogenesis, suggesting potential metabolic benefits. Willemsen et al., 2022

Summary

Inosine Injection is a metabolically active nucleoside preparation delivering 400 mg per dose. It supports energy metabolism and has roles in cardiac, neurological, and immune support contexts. While generally well tolerated when administered under supervision, it elevates serum urate, posing risks for gout, nephrolithiasis, and renal function impairment. Monitoring is essential, especially in high-risk populations. In selected cases, its use may support recovery from exhaustion or metabolic stress, under the guidance of qualified healthcare professionals.

The post Inosine Injection (5 ampoules × 400 mg/10 ml) appeared first on MeDank Online Shop.

Composition

• Active ingredient: Phytomenadione (Vitamin K1) – 10 mg per 1 ml ampoule.
• Excipients: glycocholic acid, lecithin, sodium hydroxide, hydrochloric acid, water for injections.

Description

Konakion MM 10 mg is a clear, sterile yellow-brown solution for oral or intramuscular administration. It contains a micellar solution of fat-soluble vitamin K1 designed for enhanced absorption, even in patients with impaired bile production or fat malabsorption. Manufactured by Roche Pharmaceuticals, Konakion MM is typically supplied in 1 ml glass ampoules.

Pharmacological Action

Phytomenadione (vitamin K1) is a vital cofactor for hepatic synthesis of coagulation factors II, VII, IX, and X, as well as proteins C and S. Without adequate vitamin K1, the gamma-carboxylation of glutamic acid residues in these proteins is impaired, leading to dysfunctional clotting and increased bleeding risk. Konakion MM rapidly restores physiological levels of active vitamin K1, reactivating coagulation pathways and reducing haemorrhagic complications.

Indications

Konakion MM 10 mg is indicated for:

• Prevention and treatment of vitamin K deficiency bleeding (VKDB) in neonates and infants.
• Vitamin K deficiency due to chronic liver disease, biliary obstruction, or intestinal malabsorption.
• Hypoprothrombinaemia induced by long-term antibiotic therapy.
• Antidote to overdosage or prolonged treatment with coumarin anticoagulants (e.g., warfarin).

Dosage and Administration

• **Neonates and infants**: 1–2 mg orally or intramuscularly as prophylaxis at birth or treatment in case of bleeding.
• **Adults**: 10 mg intramuscularly or orally; repeat dose as required per clinical status.
• **Warfarin reversal**: In non-urgent cases, 2.5–5 mg orally. In urgent reversal, IV route preferred under clinical supervision.
• Route of administration: Oral, intramuscular, or intravenous (off-label/emergency, with risk of anaphylaxis).

Always follow physician’s instructions. Do not self-administer intramuscular or IV injections without clinical supervision.

Contraindications

• Known hypersensitivity to phytomenadione or formulation excipients.
• Severe hepatic failure with no capacity for clotting factor synthesis.
• IV administration contraindicated unless medically justified due to rare risk of anaphylactic shock.

Side Effects

• Common: facial flushing, sweating, dizziness, taste disturbances (oral route).
• Less common: injection site pain or hematoma (IM route), mild elevation of liver enzymes.
• Rare: hypersensitivity reactions, bronchospasm, anaphylaxis (especially IV route).
• Neonates: risk of hemolysis or hyperbilirubinemia in high doses.

Precautions

• Use with caution in patients with liver disease or coagulopathies.
• Do not mix Konakion MM with other IV fluids in the same syringe or line.
• Carefully monitor INR when co-administered with anticoagulants.

Interactions

• Antagonizes the effects of vitamin K antagonists (e.g., warfarin, acenocoumarol).
• Broad-spectrum antibiotics may increase vitamin K deficiency by disrupting gut flora.
• Bile acid sequestrants (e.g., cholestyramine) reduce vitamin K absorption.
• Mineral oils, orlistat, and certain laxatives may impair absorption of fat-soluble vitamins.

Overdose and Management

Toxicity is rare due to high therapeutic index. Overdose symptoms are uncommon but may include transient flushing, hyperbilirubinemia in neonates, or hemolysis in G6PD-deficient infants. Treatment is symptomatic and supportive.

Use in Pregnancy and Lactation

Vitamin K1 does not cross the placenta efficiently; neonatal prophylaxis is essential. Konakion MM is considered safe in pregnancy at therapeutic doses. It may be used in breastfeeding women—vitamin K1 is excreted in low amounts into breast milk.

Use in Pediatrics

Neonatal prophylaxis with Konakion MM significantly reduces early and late vitamin K deficiency bleeding (VKDB). Intramuscular administration offers sustained protection, whereas oral prophylaxis may require multiple doses.

WHO Bulletin on VKDB prophylaxis

Storage

• Store in original packaging at 15–25 °C.
• Protect from light and moisture.
• Do not freeze. Keep ampoules tightly sealed until use.
• Discard after expiration date.

Clinical Studies and Evidence

A systematic review of vitamin K prophylaxis strategies showed intramuscular Konakion MM at birth prevented >95% of late VKDB compared to oral routes (Cornelissen et al., 2017). Cochrane Review

In adults on warfarin with elevated INR, low-dose oral vitamin K1 (1–2.5 mg) normalized coagulation faster than placebo without excessive clotting risk. Crowther et al., NEJM

Summary

Konakion MM 10 mg is a clinically validated formulation of vitamin K1 indicated for the prevention and treatment of deficiency states and coagulopathy. With multiple administration routes and well-established efficacy, it is considered essential for neonatal prophylaxis and adult reversal of anticoagulation. Use must be guided by medical professionals, particularly in populations at risk for liver dysfunction or bleeding disorders.

The post Konakion MM 10 mg (Vitamin K1) appeared first on MeDank Online Shop.

Composition

Each tablet of BIOTAD PLUS (Original) contains a scientifically balanced formulation of essential vitamins and minerals to support immune function, energy metabolism, and overall wellness:

• Vitamin A – 1500 mcg
• Vitamin B1 (Thiamine) – 1.5 mg
• Vitamin B2 (Riboflavin) – 1.7 mg
• Vitamin B6 – 2.0 mg
• Vitamin B12 – 6 mcg
• Vitamin C – 60 mg
• Vitamin D – 400 IU
• Vitamin E – 30 IU
• Folic Acid – 400 mcg
• Iron – 18 mg
• Calcium – 162 mg
• Zinc – 15 mg

Indications

• Prevention and correction of multivitamin deficiencies due to inadequate diet, illness, or malabsorption
• Supplementation during pregnancy, lactation, or recovery from surgery or infection
• Support in chronic illness, anemia, osteoporosis, or increased nutritional demand
• Adjunct in metabolic disorders or aging-related nutrient depletion

Contraindications

• Hypersensitivity to any component of the formulation
• Hemochromatosis, hemosiderosis, or chronic iron overload
• Active peptic ulcers or untreated hypervitaminosis A or D
• Hemolytic anemia not caused by iron deficiency

Dosage and Administration

• Recommended adult dose: 1 tablet per day with food
• In pregnancy/lactation: consult a healthcare provider for individual needs
• Do not exceed the recommended dose unless advised by a medical professional

Side Effects

BIOTAD PLUS (Original) is well-tolerated in most individuals. However, some may experience:

• Gastrointestinal upset (nausea, constipation, diarrhea)
• Metallic or unpleasant taste
• Rare: allergic skin reactions or sensitivity to iron

Precautions

• Use cautiously in individuals with kidney stones, gout, or iron storage disorders
• Monitor iron and vitamin D levels in long-term use
• Consult your physician before use in children

Interactions

• Iron may reduce absorption of tetracyclines, quinolones, and levothyroxine—space doses by at least 2 hours
• Calcium and zinc can interfere with bisphosphonates and certain antibiotics
• Alcohol and smoking may reduce the effectiveness of several B-complex vitamins

Storage

• Store at room temperature (15–25 °C) in a dry place
• Protect from direct sunlight and excessive humidity
• Keep out of reach of children

Clinical Evidence and References

Multivitamin-mineral supplements like BIOTAD PLUS are supported by clinical research for reducing the risk of micronutrient deficiency and supporting immune and cognitive health in at-risk populations:

• Fortmann SP et al., JAMA 2013
• Mikkelsen K et al., Nutrients 2016

Summary

BIOTAD PLUS (Original) is a comprehensive multivitamin and multimineral supplement designed to replenish vital nutrients. With a balanced combination of vitamins A, B-complex, C, D, E, iron, calcium, and zinc, it serves as a reliable support for immunity, energy metabolism, and general wellbeing. Always consult a healthcare professional before beginning supplementation, especially in case of preexisting conditions or medication use.

The post BIOTAD PLUS (Original) appeared first on MeDank Online Shop.

Composition

Each capsule contains 300 mg of standardized Moringa Oleifera leaf extract. Additional ingredients include microcrystalline cellulose (filler), magnesium stearate (flow agent), and hydroxypropyl methylcellulose (capsule shell).

Description

Moringavit is a dietary supplement formulated to provide essential phytonutrients, antioxidants, and micronutrients derived from Moringa Oleifera. Packed in bottles of 60 capsules, each unit offers potent nutritional support sourced from one of the most nutrient-rich plants in the world. Moringa is naturally rich in vitamins A, C, E, calcium, potassium, and essential amino acids.

Indications

• Supports nutritional balance in individuals with dietary deficiencies
• Promotes immune function and antioxidant protection
• May help maintain blood sugar levels already within the normal range
• Contributes to general wellness and energy metabolism

Contraindications

• Hypersensitivity to Moringa or any capsule components
• Pregnancy and lactation without medical supervision
• Preexisting hypotension or hypoglycemia without monitoring

Dosage and Administration

• Adults: 1 capsule per day with meals
• If recommended by a healthcare provider, dosage may be increased to 2 capsules daily
• Capsules should be swallowed whole with water and not opened or chewed

Side Effects

Moringavit is generally well-tolerated. Mild and infrequent adverse effects may include:

• Gastrointestinal discomfort (e.g., bloating, diarrhea, nausea)
• Headache or dizziness in sensitive individuals
• Rare allergic reactions: rash, itching, facial swelling, or difficulty breathing

Interactions

• May potentiate the effect of antihypertensive and hypoglycemic agents
• Should not be combined with anticoagulants without physician approval
• Consult with your healthcare provider before combining with herbal supplements or prescribed medication

Overdose

Overconsumption may result in gastrointestinal symptoms such as vomiting, cramps, or diarrhea. In case of overdose, discontinue use and seek immediate medical attention.

Storage

• Store at 15–25°C in a dry place, away from sunlight and moisture
• Keep container tightly closed after each use
• Keep out of reach of children

Scientific Evidence

• Stohs SJ et al., Phytotherapy Research 2015 – Safety and efficacy of Moringa Oleifera
• Leone A et al., Nutrients 2016 – Nutritional characterization of Moringa leaves

Summary

Moringavit offers a plant-based, nutrient-dense supplement aimed at improving vitality, supporting immune defense, and contributing to balanced nutrition. With a foundation in traditional medicine and emerging clinical validation, Moringa Oleifera presents a promising adjunct for health-conscious individuals. Use should be guided by a healthcare professional, particularly when managing chronic conditions or combining with medications.

The post Moringavit capsules 300 mg, #60 appeared first on MeDank Online Shop.

Composition

Each 2g sachet of NeoTad contains:

• Glutathione: A tripeptide composed of glutamine, cysteine, and glycine. It functions as a major intracellular antioxidant.
• Vitamin C (Ascorbic Acid): A water-soluble vitamin and antioxidant crucial for immune function and tissue repair.
• Other excipients: Natural flavorings, stabilizers, and binding agents (may vary depending on manufacturer).

Description

NeoTad is an oral dietary supplement presented as a white-to-off-white powder in individual 2g sachets. It is intended to be dissolved in water or juice prior to ingestion. The formulation combines glutathione with vitamin C to synergistically support cellular defense, skin health, detoxification, and immunity.

Pharmacological Properties

• Glutathione is the body’s primary endogenous antioxidant. It protects cellular components from oxidative damage, detoxifies xenobiotics through conjugation, supports immune response, and regenerates other antioxidants such as vitamins C and E. It also influences melanogenesis, making it popular in dermatology for skin tone balance.
• Vitamin C acts as an electron donor for various enzymatic reactions, supports collagen synthesis, enhances iron absorption, and regenerates glutathione in oxidized form. It is a co-factor in carnitine synthesis and neuropeptide metabolism.

Co-administration of glutathione and vitamin C improves the pharmacokinetic profile and intracellular retention of glutathione, as vitamin C stabilizes its reduced form and inhibits oxidative degradation.

Indications

NeoTad is recommended as a supportive therapy in the following cases:

• General antioxidant support and immune enhancement
• Skin rejuvenation, pigmentation modulation, and dermatological health
• Support during detoxification protocols
• Oxidative stress-related conditions (e.g., chronic inflammation, pollution exposure)
• Supportive therapy during chemotherapy, liver disease, or HIV treatment (under medical supervision)

Contraindications

• Known hypersensitivity to glutathione, vitamin C, or formulation excipients
• Patients with oxalate kidney stones or renal impairment (due to high-dose vitamin C)
• Pregnant or breastfeeding women without physician recommendation

Dosage and Administration

• Standard dose: One sachet (2g) once daily
• Administration: Dissolve in 150–200 ml of water or juice; consume immediately after preparation
• May be taken with or without food
• Dosage may be increased to twice daily under medical supervision for intensive therapy

Overdose and Management

Overdose is uncommon but may result in symptoms such as:

• Nausea
• Abdominal cramps
• Diarrhea
• Oxaluria (from excessive vitamin C intake)

Supportive and symptomatic care is advised in overdose cases. Maintain hydration and monitor renal function if necessary.

Side Effects

• Occasional gastrointestinal discomfort (nausea, bloating, or diarrhea)
• Rare allergic reactions: rash, pruritus, or swelling
• Very high doses of vitamin C may increase oxalate levels in urine

Special Precautions

• Monitor renal function in patients with a history of kidney stones
• Inform laboratory staff of glutathione or high-dose vitamin C use, as it may affect certain biochemical assays
• Consult a healthcare provider before use in pregnancy, lactation, or chronic medical conditions

Drug Interactions

• May reduce the efficacy of certain chemotherapeutic agents by acting as an antioxidant
• May enhance iron absorption (via vitamin C), caution in hemochromatosis
• Glutathione may interact with nitroglycerin, leading to potential hypotension

Storage

• Store below 25°C in a dry place
• Keep sachets in original packaging until use
• Protect from direct sunlight and moisture
• Keep out of reach of children

Scientific Support

• Matsuyama et al. 2014 – Glutathione skin-lightening and antioxidant action
• Rizwan et al. 2018 – Synergistic antioxidant role of glutathione and vitamin C

Summary

NeoTad sachets provide an effective antioxidant combination of glutathione and vitamin C. Their synergistic action supports immune function, combats oxidative stress, and contributes to improved skin tone and tissue repair. Safe for daily use, NeoTad is a valuable addition to wellness routines, provided precautions are followed and medical guidance is obtained in special populations.

The post NeoTad (Glutathione with Vitamin C, powder, 20 sachets of 2 g) appeared first on MeDank Online Shop.

BioFosfina (Original) Solution is a therapeutic injectable supplement developed to support recovery and improve cellular energy metabolism. Known for its safety profile and tolerability, BioFosfina is commonly used in managing fatigue, neuropathy, and recovery post-surgery. Its formulation enhances mitochondrial function, supports nerve conduction, and aids in systemic regeneration.

Composition

Each 1 ml of BioFosfina (Original) Solution contains:

• Biofosfina (100 mg): A proprietary phosphoric compound supporting cellular metabolism
• Sodium chloride: Maintains isotonicity
• Benzyl alcohol: Preservative
• Water for injection

Description

BioFosfina is a sterile, colorless injectable solution, presented in ampoules for intramuscular or slow intravenous administration. It is primarily utilized as a supportive agent in conditions characterized by cellular energy deficiency or increased metabolic demand.

Pharmacological Properties

The active compound in BioFosfina plays a critical role in ATP regeneration and the Krebs cycle, contributing to enhanced cellular respiration and energy production. It supports peripheral nerve regeneration and improves neuromuscular transmission. This makes it effective in both neurological and physical fatigue conditions.

Indications

BioFosfina is indicated in the following conditions:

• Chronic fatigue syndrome
• Peripheral neuropathy (diabetic, post-viral, idiopathic)
• Postoperative recovery
• Asthenia associated with chronic disease
• General metabolic support in convalescence

Dosage and Administration

• Standard adult dose: 1 ampoule per day via intramuscular injection or slow intravenous infusion
• Duration: Typically 5 to 10 days, depending on clinical condition
• Dosage may be adjusted based on age, weight, and response to therapy
• Only a licensed healthcare provider should administer this product

Contraindications

• Hypersensitivity to any ingredient of the solution
• Severe renal insufficiency
• Metabolic acidosis
• Patients with known phosphate metabolism disorders

Side Effects

Most patients tolerate BioFosfina well. However, possible adverse reactions include:

• Mild nausea or gastrointestinal discomfort
• Headache
• Local pain, redness, or swelling at injection site
• Rare allergic reactions (rash, pruritus)

Precautions

• Use cautiously in patients with renal impairment or electrolyte imbalance
• Monitor serum phosphate levels in prolonged therapy
• Inform physician of any pre-existing metabolic or cardiovascular conditions

Interactions

• Concomitant use with calcium-containing solutions may lead to precipitation
• Potential interaction with other phosphate or potassium supplements
• Inform healthcare provider of all concurrent medications and supplements

Overdose

Overdose may result in symptoms such as:

• Severe gastrointestinal upset
• Dizziness or confusion
• Electrolyte disturbances

In case of suspected overdose, initiate supportive and symptomatic care immediately. Monitor renal function and serum electrolytes.

Storage

• Store at 15–25°C (59–77°F)
• Protect from light and moisture
• Do not freeze
• Keep out of reach of children and pets

Additional Information

BioFosfina is a prescription medication and must only be used under medical supervision. Ensure correct dilution and administration technique. Periodic monitoring may be necessary in long-term treatment courses. Report any unusual or persistent symptoms to a healthcare provider promptly.

Scientific Reference

• Lanza et al. – Phosphate compounds in fatigue and nerve repair

The post BioFosfina (Original) 5 mg – 20 sachets appeared first on MeDank Online Shop.

Composition

Each 10 ml of Turboguarin contains:

• Guarana Extract – 200 mg
• Ginseng Root Extract – 150 mg
• Green Tea Extract – 100 mg
• Vitamin B12 – 2.4 μg

Other ingredients: purified water, natural flavoring agents. No artificial sweeteners or preservatives included.

Description

Turboguarin is a liquid, plant-based supplement developed to provide a natural energy boost. Designed for quick absorption, it combines traditional herbal stimulants with essential vitamins to support alertness, stamina, and mental performance. Unlike many commercial energy drinks, Turboguarin avoids synthetic compounds and relies on the natural synergy between Guarana, Ginseng, and Green Tea to enhance physical and cognitive endurance without the crash.

Pharmacological Properties

• Guarana: A rich natural source of caffeine, providing sustained stimulation and reduced fatigue.
• Ginseng: Traditionally used to enhance vitality and concentration; known for adaptogenic properties.
• Green Tea Extract: Contains L-theanine, which balances the stimulating effects of caffeine, promoting focused calmness.
• Vitamin B12: Vital for energy metabolism, nervous system function, and red blood cell formation.

This synergistic blend supports mitochondrial activity, oxygen delivery, and mental clarity under stress or fatigue.

Indications

Turboguarin is recommended in the following scenarios:

• Mental and physical fatigue
• Long working hours or study sessions
• Before workouts or physical exertion
• General energy support in active individuals

Dosage and Administration

• Recommended dose: 10 ml once or twice daily
• Can be consumed directly or diluted in water or juice
• Best taken in the morning or early afternoon to avoid interference with sleep

Shake well before use. Do not exceed 20 ml in 24 hours without medical supervision.

Contraindications

• Hypersensitivity to any ingredient in the formulation
• Pregnant or breastfeeding women (unless approved by a healthcare provider)
• History of cardiovascular disease, arrhythmias, or hypertension

Precautions

• Do not combine with other caffeinated products to avoid overstimulation
• Not suitable for children under 18 years of age
• Discontinue use if insomnia, palpitations, or irritability occur
• Consult a doctor before use if you have chronic health conditions or take medications

Side Effects

Most users tolerate Turboguarin well. Potential side effects may include:

• Jitters or restlessness
• Difficulty falling asleep (especially if taken late)
• Increased heart rate
• Digestive upset or mild nausea

In rare cases, allergic reactions (rash, swelling, dizziness) may occur.

Interactions

May interact with the following:

• Stimulant medications or supplements
• Beta-blockers and other blood pressure medications
• Antidepressants and MAO inhibitors

Always disclose supplement use to your healthcare provider if taking prescription drugs.

Overdose

Excessive intake may lead to caffeine overdose symptoms:

• Insomnia, restlessness, and anxiety
• Tachycardia or palpitations
• Gastrointestinal distress

Seek immediate medical attention if overdose is suspected.

Storage

• Store at room temperature (15–25°C)
• Protect from sunlight and heat
• Keep tightly sealed after opening
• Keep out of reach of children

Packaging

Available in 100 ml amber bottles with a measuring cap for accurate dosing.

Manufacturer

NaturalBoost Inc., a certified producer of plant-based nutritional supplements, focused on purity, efficacy, and sustainable sourcing.

Scientific References

• Haskell et al. – Effects of Guarana and caffeine on cognitive performance
• Kennedy et al. – Improved performance following a ginseng-containing supplement

The post Turboguarin (Plant-Based Energy Booster) appeared first on MeDank Online Shop.